Risk and outcomes of COVID‐19 in patients with multiple sclerosis

Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

(2021) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore

(2020) Barnaby Edward Young et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

COVID-19: the gendered impacts of the outbreak

(2020) Clare Wenham et al.   LANCET

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictors of Hospitalization in a Canadian MS Population: a Matched Cohort Study

(2020) Lina H Al-Sakran et al.   Multiple Sclerosis and Related Disorders

SARS‐CoV ‐2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad

(2020) Sandra Amor et al.   ANNALS OF NEUROLOGY

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

(2020) Chuan Qin et al.   CLINICAL INFECTIOUS DISEASES

Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D

(2020) Sandro La Vignera et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal

(2020) Hasan K. Siddiqi et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2

(2020) M. D. Willis et al.   JOURNAL OF NEUROLOGY

COVID-19: consider cytokine storm syndromes and immunosuppression

(2020) Puja Mehta et al.   LANCET

Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic

(2020) Lorenzo D’Antiga   LIVER TRANSPLANTATION

Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

(2020) Mandeep R. Mehra et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 and MS disease-modifying therapies

(2020) Joseph R. Berger et al.   Neurology-Neuroimmunology & Neuroinflammation

Gender Differences in Patients With COVID-19: Focus on Severity and Mortality

(2020) Jian-Min Jin et al.   Frontiers in Public Health

COVID-19 in multiple sclerosis: The Dutch experience

(2020) Floor C Loonstra et al.   Multiple Sclerosis Journal

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

(2020) Céline Louapre et al.   JAMA Neurology

COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

(2020) Giovanni Novi et al.   Multiple Sclerosis and Related Disorders

The prevalence of MS in the United States

(2019) Mitchell T. Wallin et al.   NEUROLOGY

Infection Risk in Patients on Multiple Sclerosis Therapeutics

(2015) Eric M. Williamson et al.   CNS DRUGS

Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain

(2012) S. Otero-Romero et al.   Multiple Sclerosis Journal